Recently, Leishman and colleagues reported that inhibition of ERAP1 in “hot” tumor models, such as melanoma and colorectal cancer, results in the generation of new epitopes derived from several cancer-associated proteins [57]. This evidence concerns the gene ERAP1 and neoplasm.